Used in solid-phase peptide synthesis as a protected amino acid building block, particularly in the preparation of complex peptides and peptidomimetics. The Fmoc group provides temporary N-terminal protection that is stable under acidic conditions but can be selectively removed under mild basic conditions, allowing stepwise assembly of peptide chains. The 3,4-dimethoxyphenylalanine moiety introduces a modified aromatic side chain that can influence peptide conformation, stability, and biological activity. Commonly employed in research settings for developing pharmaceuticals, studying structure-activity relationships, and synthesizing bioactive peptides with enhanced metabolic stability or receptor selectivity.